Data analysis from BRCA1 and BRCA2 mutation carriers together found no effect of RRSO together with risk-reducing mastectomy on breast cancer mortality.28 Clinical trials of interval salpingectomy and delayed oophorectomy are ongoing. Here, BRCA2 is linked to breast carcinoma.